Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.54 USD | +3.16% | +4.12% | +37.59% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.59% | 6.32B | |
+45.07% | 54.63B | |
-7.02% | 39.92B | |
+37.07% | 38.82B | |
+12.74% | 26.86B | |
-11.17% | 26.22B | |
-22.12% | 18.78B | |
+24.80% | 12.21B | |
-0.05% | 12.16B | |
+24.94% | 11.94B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Price Target on Revolution Medicines to $34 From $35, Maintains Buy Rating